Three-year surveillance of community-acquired Staphylococcus aureus infections in children.

By S. Kaplan, K. Hulten, B. E. Gonzalez, Wendy A. Hammerman, L. Lamberth, James Versalovic, E. Mason. Clinical Infectious Diseases, 2005

613 citations recorded by the source corpus.

Subfields: Infectious Diseases, Molecular Biology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/dcc55b36d16582b84d9d34fd2fc13aa574982077

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. D. Levine
2. Robert S. Daum
3. S. Cosgrove
4. H. Boucher
5. G. Corey
6. L. Chiarello
7. J. Siegel
8. M. Jackson

In Molecular Biology

1. L. Chiarello
2. Henry F. Chambers
3. J. Siegel
4. Robert S. Daum
5. M. Jackson
6. E. Rhinehart

In Public Health, Environmental and Occupational Health

1. S. Cosgrove
2. Henry F. Chambers
3. Robert S. Daum
4. T. Dellit

Citations in the corpus

• Epidemiology of methicillin-resistant Staphylococcus aureus. (2008, background): “These include necrotizing fasciitis [59], Waterhouse-Friderichsen syndrome [60], empyema [61], postinfluenza pneumonia [33, 62], septic thrombophlebitis [58], pyomyositis with or without osteomyelitis or septic arthritis [63, 64], and bacteremia [57].”
• 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings (2007, background): “When ASC are obtained as part of an intensified MDRO control program, implement contact precautions until the surveillance culture is reported negative for the target MDRO.(8,30,153,389,390) Category IB.”
• Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. (2008, neutral): “ing resistance to non– -lactam agents [10].”
• Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. (2011, background): “Clindamycin is active against b- hemolytic streptococci, although MRSA susceptibility rates may vary by region [85, 124, 125].”